参考文献/References:
[1]Wild S,Roglic G,Green A,et al.Global prevalence of diabetes:estimates for the year 2000 and projections for 2030[J].DiabetesCare,2004,27(5):1047-1053. [2]Cho NH,Shaw JE,Karuranga S,et al.IDF diabetes atlas:global estimates of diabetes prevalence for 2017 and projections for 2045[J].Diabetes Research And Clinical Practice,2018(138):271-281. [3]Lambrinou E,Hansen TB,Beulens JW.Lifestyle factors,self-management andpatient empowerment in diabetes care[J].European Journal of Preventive Cardiology,2019,26(2S):55-63. [4]丁晶晶,刘吴瑕,徐仲卿.卫生健康事业发展70周年巡礼·慢性病管理[J].中国临床保健杂志, 2019,22(4):439-442. [5]祝旭.大数据背景下慢性病健康管理系统的构建与应用研究[J].信息与电脑(理论版),2019(7):12-14. [6]Martin-Sanchez F,Verspoor K.Big data in medicine is driving big changes[J].IMIA Yearbook of Medical Informatics,2014,9(1):14-20. [7]Ola O,Sedig K.The challenge of big data in public health:anopportunity for visual analytics[J].Online Journal of Public Health Informatics,2014,5(3):223. [8]柳小平,李鼎然,肖敏,等.智慧医疗背景下慢性病健康管理服务设计研究[J].科学经济导刊,2020,28(11):15-16. [9]肖婧婧,李华才.美国推出电子健康档案安全报告系统[J].中国数字医学,2011,6(5):7. [10]王佐卿,王树山,邱洪斌,等.新医改模式下区域卫生信息化建设的探讨[J].中国医院管理,2010,30(11):47-48. [11]彭晓敏.英国慢性非传染性疾病管理经验带来的思考和借鉴[J].中华全科医师杂志,2017,16(5):410-412. [12]周毅,梅芝雨.基于互联网模式的慢病管理系统设计与实践[J].中国数字医学2018,13(1):38-40. 13]赵笑颜,王嘉阳,王昀.大数据在慢病管理中的应用[J].解放军医院管理杂2019,26(1):1-4. [14]Zhai Y,Zhu W,Cai Y,et al.Clinical andcost-effectiveness of telemedicine in type 2diabetes mellitus:a systematic reviewand meta-analysis[J].Medicine,2014,93(28):e312.. [15]Weinstock RS,Teresi JA,Goland R,et al.Glycemiccontrol and health disparities in older ethnically diverse underservedadults with diabetes:five-year results from the informatics fordiabetes education and telemedicine study[J].Diabetes Care,2011,34(2):274-279. [16]Quinn CC,Shardell MD,Terrin ML,et al.Cluster-randomizedtrial of a mobilePhone personalized behavioralintervention for blood glucose control[J].Diabetes Care,2011,34(9):1934-1942. [17]Lopez L,Grant RW.Closing the gap:eliminatinghealth care disparities among Latinos withdiabetes using health information technologytools and patient navigators[J].Journal of Diabetes Science and Technology,2012,6(1):169-176. [18]Stone RA,Rao RH,Sevick MA,et al.Active care managementsupported by home telemonitoring in veterans with type 2 diabetes:the DiaTel randomized controlled trial[J].Diabetes Care,2010,33(3):478-484. [19]Kang B,Cho JH.Potential of OneTouch Diabetes Management Software System in Real Field for Korean Type 2 Diabetes Patients[J]. Diabetes &Metabolism Journal,2016(40):115-117. [20]Mora P,Buskirk A,Lyden M,et al.Use of a Novel,Remotely Connected DiabetesManagementSystem Is Associated withIncreasedTreatment Satisfaction,Reduced Diabetes Distress,and Improved Glycemic Control in Individualswith Insulin-Treated Diabetes:First Results from the Personal DiabetesManagement Study[J].Diabetes Technology &Therapeutics,2017,19(12):715-722. [21]Given JE,O’Kane MJ,Bunting BP,et al.Comparingpatient-generated blood glucose diary records with metermemory in diabetes:a systematic review[J].Diabetic Medicine,2013,30(8):901-913. [22]Al-Ofi EA,Mosli HH,Ghamri KA,et al.Management ofPostprandialhyperglycaemia andweight gain in women with gestational diabetesmellitus using a novel telemonitoring system[J].Journal of International Medical Research,2019,47(2):754-764. [23]殷慧慧,杜建玲,王艾红,等.国家标准化代谢性疾病管理中心应用于糖尿病患者管理的效果研究[J].中国全科医学杂志http://kns.cnki.net/kcms/detail/13.1222.R.20191224.0950.016.html [24]McCoy RG,Van Houten HK,Ziegenfuss JY,et al.Increased Mortality of Patients With Diabetes Reporting SevereHypoglycemia[J].Diabetes Care,2012,35(9):1897-1901. [25]叶山东.2型糖尿病患者个体化血糖达标对策[J].中国临床保健杂志,2014,17(1):1-2. [26]林嘉敏,肖柳红,张舒婷,等.基于代谢性疾病管理中心平台健康教育在出院后2型糖尿病患者中的应用[J].现代临床护理,2019,18(2):57-62. [27]于洪涛,唐仕炜,郝涛,等.县级医院建立国家标准化代谢性疾病管理基层中心的探讨[J].中国药业,2019,28(15):70-72. [28]Xu Y,Wang L,He J,et al.Prevalence and control of diabetesin Chinese adults[J].JAMA,2013,310(9):948-959. [29]黄砚萍,吴蕾,毛凡,等.社区“5+1”糖尿病分阶段达标管理模式对 2 型糖尿病并发症筛查的干预效果[J].中国慢性病预防与控制,2019,27(4):247-251. [30]方萍.中国Ⅰ型糖尿病智能化管理与大数据中心在中科大附一院成立[J].安徽卫生职业技术学院学报,2019(5):37. [31]刘桂芳,莫结霞,黄素枰,等.基于跨理论模型的社区家庭访视护理在社区糖尿病高危人群中的应用[J].全科护理,2018,16(15):114-116. [32]Klionsky DJ,Abdelmohsen K,Abe A,et al.Evaluation of US Veterans Nutrition Education for Diabetes Prevention[J].Journal of Nutrition Education and Behavior,2016,48(8):538-543. [33]赵闻平,张勰,杨丽.糖尿病高危人群健康管理的原则及食物血糖生成指数刍议[J].全科口腔医学电子杂志,2019,6(31):165,173. [34]薛宏丽,顾瑞霞.糖尿病高危人群的健康管理策略分析[J].中国医药指南2016,14(7):151-151. [35]蔡穗珍,吴俊泉,俞洁,等.基于体检大数据的糖尿病高危人群管理平台的前期建设[J].福建医药杂志,2019,41(2):143-144. [36]牟海燕,陈敏.健康医疗大数据开放管理探讨[J].中华医院管理杂志,2019,35(8):660-663. [37]UK Prospective Diabetes Study (UKPDS).Ⅷ. Study design, progress and performance[J].Diabetologia,1991,34(12):877-890. [38]曾龙驿.英国前瞻性糖尿病研究(UKPDS)解读[J].中国卒中杂志,2007,2(7):639-640. [39]王姮.美国糖尿病学会颁布DCCT研究成果[J].中华内分泌代谢杂志,1993,9(4):256. [40]唐文涛,岩崎宏介.基于日本医疗大数据的糖尿病诊疗延误负担的经济学评价[J].中国循证医学杂志,2019,19(4):392-397. [41]闫冠韫,陈洪恩,李舜,等.大数据视阈下糖尿病患者管理模式探析[J].中国全科医学,2018, 21(9):1066-1069,1084. [42]马计,杭波,高凌.糖尿病并发症信息管理系统的设计与实现[J].中国数字医学,2017,12(7):51-54. [43]Kavakiotis I,Tsave O,Salifoglou A,et al.Machine Learning and Data Mining Methods in Diabetes Research[J].Computational and Structural Biotechnology Journal,2017(15):104-116. [44]Bellazzi R,Dagliati A,Sacchi L,et al.Big Data Technologies: New Opportunities for Diabetes Management[J].Journal of Diabetes Science and Technology,2015,9(5):1119-1125. [45]Rumbold JMM,O’Kane M,Philip N,et al.Big Data and diabetes: the applications of Big Data for diabetes care now and in the future[J].Diabetic Medicine,2020,37(3):187-193. [46]Chen S,Burstrom B,Sparring V,et al.Vertical integrate dservice model:an educational intervention for chronic disease management and its effects in rural China-a study protocol[J].BMC Health Services Research,2018,18(1):567. [47]Fagherazzi G,Ravaud P.Digital diabetes:Perspectives for diabetes prevention, management and research[J].Diabetes&Metabolism,2019,45(4):322-329. [48]Choudhary P,Amiel SA.Hypoglycaemia in type 1 diabetes:technological treatments,theirlimitations and the place of psychology[J].Diabetologia,2018,61(4):761-769.
相似文献/References:
[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal
Cancer[J].Medical Information,2018,31(19):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]耿金萍.综合护理对甲状腺良性肿瘤并糖尿病患者手术效果的影响分析[J].医学信息,2018,31(01):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
GENG Jin-ping.Analysis of the Effect of Comprehensive Nursing on the Surgical Effect of Thyroid Benign
Tumor and Diabetic Patients[J].Medical Information,2018,31(19):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
[3]李雯婷,谈世华,余江明,等.踝肱指数检测在住院糖尿病患者中的重复性研究[J].医学信息,2018,31(03):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
LI Wen-ting,TAN Shi-hua,YU Jiang-ming,et al.Study on Reproducibility of Ankle-brachial Index in Inpatients with Diabetes Mellitus[J].Medical Information,2018,31(19):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
[4]刘 静.冠状动脉粥样硬化性心脏病合并糖尿病的血脂检验结果分析[J].医学信息,2018,31(04):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
LIU Jing.Analysis of Blood Lipid Test Results in Coronary Atherosclerotic Heart Disease Complicated with Diabetes Mellitus[J].Medical Information,2018,31(19):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
[5]谢勇丽,苏晓清,张雅薇.糖尿病痛性周围神经病变患者情绪调查分析[J].医学信息,2018,31(05):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
XIE Yong-li,SU Xiao-qing,ZHANG Ya-wei.Investigation and Analysis of Mood in Patients with Diabetic Peripheral Neuropathy[J].Medical Information,2018,31(19):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
[6]张雅薇,朱明慧.首发为动眼神经麻痹的糖尿病合并动眼神经麻痹误诊为痛性眼肌麻痹1例分析[J].医学信息,2018,31(05):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
ZHANG Ya-wei,ZHU Ming-hui.An Analysis of a Case of Diabetes Mellitus with Oculomotor Nerve Palsy Misdiagnosed as Painful Ophthalmoplegia[J].Medical Information,2018,31(19):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
[7]张宇宁.黄酮类化合物治疗糖尿病及其并发症的研究[J].医学信息,2018,31(05):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
ZHANG Yu-ning.Study on Flavonoids in the Treatment of Diabetes Mellitus and its Complications[J].Medical Information,2018,31(19):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
[8]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的
临床效果观察[J].医学信息,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Medical Information,2018,31(19):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
[9]吕桂英.影响糖尿病患者药物治疗依从性相关因素临床分析[J].医学信息,2018,31(08):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
LV Gui-ying.Clinical Analysis of Factors Related to Compliance with Drug Therapy in Patients with Diabetes Mellitus[J].Medical Information,2018,31(19):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
[10]刘爱君.糖化血红蛋白测定在糖尿病诊断中的应用价值分析[J].医学信息,2018,31(08):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]
LIU Ai-jun.Analysis of the Value of Determination of Glycosylated Hemoglobin in the Diagnosis of Diabetes Mellitus[J].Medical Information,2018,31(19):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]